Variation in Antibiotic Prescribing Across a Pediatric Primary Care Network

Jeffrey S Gerber1, Priya A Prasad2, A Russell Localio3

  • 1Divisions of Infectious Diseases The Center for Pediatric Clinical Effectiveness Departments of Pediatrics Biostatistics and Epidemiology Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.

Insights

Antibiotic prescribing for pediatric respiratory infections varies widely between practices, even after accounting for patient factors. This highlights significant opportunities for improving antimicrobial stewardship in outpatient settings.

Area of Science:

  • Pediatric infectious diseases
  • Antimicrobial stewardship
  • Health services research

Background:

  • Outpatient respiratory tract infections are a leading cause of antibiotic prescriptions in children.
  • Previous research indicates antibiotic overuse, but lacks detailed data on practice-level variability.

Purpose of the Study:

  • To investigate the variability in antibiotic prescribing for pediatric acute respiratory tract infections across different outpatient practices.
  • To identify potential determinants of this prescribing variability.

Main Methods:

  • Retrospective cohort study of 399,793 acute visits to 25 pediatric practices (222 clinicians) in 2009.
  • Data extracted from electronic health records, including diagnoses, medications, and patient demographics.
  • Analysis adjusted for patient factors and clinician clustering to compare practice-level prescribing rates.

Main Results:

  • 28% of acute visits resulted in antibiotic prescriptions.
  • Antibiotic prescribing rates varied from 18% to 36% across practices, with broad-spectrum antibiotic use ranging from 15% to 58%.
  • Significant practice-level variation was observed in diagnoses and broad-spectrum antibiotic prescribing for common infections like otitis media, sinusitis, pharyngitis, and pneumonia.

Conclusions:

  • Substantial unexplained variability exists in antibiotic prescribing for common pediatric infections among outpatient practices.
  • Patient-specific factors do not account for this observed prescribing variation.
  • These findings underscore the need for targeted antimicrobial stewardship interventions in pediatric outpatient settings.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
373
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
744
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
704
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
462
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
32